New drug combo may speed up emergency intubation
NCT ID NCT05509192
First seen Feb 22, 2026 · Last updated Jun 19, 2026 · Updated 15 times
Summary
This study tested a new method (MTPI) for giving anesthesia drugs to make inserting a breathing tube faster and easier. It involved 154 adults with higher airway risk (e.g., obesity). The goal was to see if MTPI works better than the standard approach.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANESTHESIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
rocuronium and propofol
What this could lead to
If successful, this could lead to faster and safer intubation techniques for patients with difficult airways.
What could go wrong
This is a small, completed Phase 4 trial with 154 participants, so results may not apply to all patients. The study focuses on timing and success rates, not long-term outcomes.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.